268 related articles for article (PubMed ID: 21584635)
1. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
[TBL] [Abstract][Full Text] [Related]
2. Chemoembolization of hepatic malignancy.
Gonsalves CF; Brown DB
Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
[TBL] [Abstract][Full Text] [Related]
3. Radioembolization of liver tumors with yttrium-90 microspheres.
Ahmadzadehfar H; Biersack HJ; Ezziddin S
Semin Nucl Med; 2010 Mar; 40(2):105-21. PubMed ID: 20113679
[TBL] [Abstract][Full Text] [Related]
4. Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Coldwell D; Sangro B; Salem R; Wasan H; Kennedy A
Am J Clin Oncol; 2012 Apr; 35(2):167-77. PubMed ID: 21127414
[TBL] [Abstract][Full Text] [Related]
5. Arterial therapies of colorectal cancer metastases to the liver.
de Baere T; Deschamps F
Abdom Imaging; 2011 Dec; 36(6):661-70. PubMed ID: 21681492
[TBL] [Abstract][Full Text] [Related]
6. Radioembolization (yttrium-90 microspheres) for primary and metastatic hepatic malignancies.
Kennedy AS; Salem R
Cancer J; 2010; 16(2):163-75. PubMed ID: 20404614
[TBL] [Abstract][Full Text] [Related]
7. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.
Murthy R; Kamat P; Nunez R; Madoff DC; Gupta S; Salem R; Yao JC
J Vasc Interv Radiol; 2008 Jan; 19(1):145-51. PubMed ID: 18192482
[TBL] [Abstract][Full Text] [Related]
8. Y90 Clinical Data Update: Cholangiocarcinoma, Neuroendocrine Tumor, Melanoma, and Breast Cancer Metastatic Disease.
Padia SA
Tech Vasc Interv Radiol; 2019 Jun; 22(2):81-86. PubMed ID: 31079715
[TBL] [Abstract][Full Text] [Related]
9. 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.
Rhee TK; Lewandowski RJ; Liu DM; Mulcahy MF; Takahashi G; Hansen PD; Benson AB; Kennedy AS; Omary RA; Salem R
Ann Surg; 2008 Jun; 247(6):1029-35. PubMed ID: 18520231
[TBL] [Abstract][Full Text] [Related]
10. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
John PK; Saif MW
JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
[TBL] [Abstract][Full Text] [Related]
11. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres.
Mulcahy MF; Lewandowski RJ; Ibrahim SM; Sato KT; Ryu RK; Atassi B; Newman S; Talamonti M; Omary RA; Benson A; Salem R
Cancer; 2009 May; 115(9):1849-58. PubMed ID: 19267416
[TBL] [Abstract][Full Text] [Related]
12. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases.
Jakobs TF; Hoffmann RT; Dehm K; Trumm C; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Helmberger TK; Reiser MF
J Vasc Interv Radiol; 2008 Aug; 19(8):1187-95. PubMed ID: 18656012
[TBL] [Abstract][Full Text] [Related]
13. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Fidelman N; Kerlan RK
AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
[TBL] [Abstract][Full Text] [Related]
14. [Chemoperfusion and embolization in the treatment of liver metastases].
Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T
Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865
[TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results.
de Baere T; Deschamps F; Teriitheau C; Rao P; Conengrapht K; Schlumberger M; Leboulleux S; Baudin E; Hechellhammer L
J Vasc Interv Radiol; 2008 Jun; 19(6):855-61. PubMed ID: 18503899
[TBL] [Abstract][Full Text] [Related]
16. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.
Kuei A; Saab S; Cho SK; Kee ST; Lee EW
World J Gastroenterol; 2015 Jul; 21(27):8271-83. PubMed ID: 26217079
[TBL] [Abstract][Full Text] [Related]
17. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.
Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS
J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765
[TBL] [Abstract][Full Text] [Related]
18. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
Nazario J; Gupta S
Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
[TBL] [Abstract][Full Text] [Related]
19. Hepatic abscess after yttrium-90 radioembolization for islet-cell tumor hepatic metastasis.
Mascarenhas NB; Mulcahy MF; Lewandowski RJ; Salem R; Ryu RK
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):650-3. PubMed ID: 19688373
[TBL] [Abstract][Full Text] [Related]
20. Yttrium-90 radioembolization using TheraSphere in the management of primary and secondary liver tumors.
Riaz A; Lewandowski RJ; Kulik L; Salem R
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):311-6. PubMed ID: 19521310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
